1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI)

ABSTRACT:

SUBMITTER: Alexander B 

PROVIDER: S-EPMC7777495 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature